Keeping pace with the rapidly evolving glaucoma space, GT: The Podcast brings the latest thought-provoking information and insights on glaucoma to the ophthalmic community. Leading experts discuss the many developments advancing the understanding and treatment of the disease, with the collective goal of ushering in a new era of glaucoma care. GT: The Podcast is produced by Bryn Mawr Communications and Glaucoma Today.
All content for GT: The Podcast is the property of Glaucoma Today and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Keeping pace with the rapidly evolving glaucoma space, GT: The Podcast brings the latest thought-provoking information and insights on glaucoma to the ophthalmic community. Leading experts discuss the many developments advancing the understanding and treatment of the disease, with the collective goal of ushering in a new era of glaucoma care. GT: The Podcast is produced by Bryn Mawr Communications and Glaucoma Today.
Francesca Cordeiro, MD, PhD, MRCP, FRCOphth, recaps her article, “DARC: From Bench to Bedside,” which was featured in the March/April issue of Glaucoma Today. In her article, she reviews a novel retinal biomarker—the Detection of Apoptosing Retinal Cells (DARC)—and its potential to function as a surrogate endpoint in glaucoma and other neurodegenerative conditions.
GT: The Podcast
Keeping pace with the rapidly evolving glaucoma space, GT: The Podcast brings the latest thought-provoking information and insights on glaucoma to the ophthalmic community. Leading experts discuss the many developments advancing the understanding and treatment of the disease, with the collective goal of ushering in a new era of glaucoma care. GT: The Podcast is produced by Bryn Mawr Communications and Glaucoma Today.
